Global Circulating Tumor Cell (CTC) Diagnostics Market Size, Status and Forecast 2020-2026

Published: December 2020

No. of Pages: 125

Price:

Single User License: US $ 3900 US $ 2925
Corporate User License: US $ 7800 US $ 5850

Report Description
Table of Contents

Circulating Tumor Cell (CTC) Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cell (CTC) Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
- CTC Enrichment
- CTC Detection

Market segment by Application, split into
- Hospitals and clinics
- Pharmaceuticals and biotechnology companies
- Academic research institutes
- CROs

Based on regional and country-level analysis, the Circulating Tumor Cell (CTC) Diagnostics market has been segmented as follows:
- North America
- - United States
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Australia
- Latin America
- - Mexico
- - Brazil
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - UAE

In the competitive analysis section of the report, leading as well as prominent players of the global Circulating Tumor Cell (CTC) Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
- ApoCell, Inc.(US)
- Biocep Ltd. (Israel)
- Biocept, Inc.(US)
- Biofluidica MicrotechnologiesLLc(US)
- Celltraffix Inc.(US)
- ClearbridgeBiomedics(Singapore)
- Creatv Microtech, Inc.(US)
- CynvenioBiosystems, Inc.(US)
- EpicBiosciencesInc.(US)
- FluxionBiosciences, Inc.(US)
- Ikonisys, Inc.(US)
- IVDiagnostics, Inc.(US)
- JanssenDiagnosticsLLc(US)
- QIAGEnHannoverGmbH (Germany)
- RARECELLsSAs(Italy)
- ScreenCell(France)

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 CTC Enrichment
1.3.3 CTC Detection
1.4 Market by Application
1.4.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Application: 2020 VS 2026
1.4.2 Hospitals and clinics
1.4.3 Pharmaceuticals and biotechnology companies
1.4.4 Academic research institutes
1.4.5 CROs
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Perspective (2015-2026)
2.2 Circulating Tumor Cell (CTC) Diagnostics Growth Trends by Regions
2.2.1 Circulating Tumor Cell (CTC) Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Circulating Tumor Cell (CTC) Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Circulating Tumor Cell (CTC) Diagnostics Industry Dynamic
2.3.1 Circulating Tumor Cell (CTC) Diagnostics Market Trends
2.3.2 Circulating Tumor Cell (CTC) Diagnostics Market Drivers
2.3.3 Circulating Tumor Cell (CTC) Diagnostics Market Challenges
2.3.4 Circulating Tumor Cell (CTC) Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Market Size
3.1.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cell (CTC) Diagnostics Revenue
3.4 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio
3.4.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2019
3.5 Key Players Circulating Tumor Cell (CTC) Diagnostics Area Served
3.6 Key Players Circulating Tumor Cell (CTC) Diagnostics Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cell (CTC) Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Circulating Tumor Cell (CTC) Diagnostics Breakdown Data by Type
4.1 Global Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Type (2021-2026)

5 Circulating Tumor Cell (CTC) Diagnostics Breakdown Data by Application
5.1 Global Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2026)
6.2 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
6.3 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)
6.4 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2026)
7.2 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
7.3 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)
7.4 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2026)
8.2 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
8.3 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)
8.4 Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia

9 Latin America
9.1 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2026)
9.2 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
9.3 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)
9.4 Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2026)
10.2 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
10.3 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)
10.4 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE

11Key Players Profiles
11.1 ApoCell, Inc.(US)
11.1.1 ApoCell, Inc.(US) Company Details
11.1.2 ApoCell, Inc.(US) Business Overview
11.1.3 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.1.4 ApoCell, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020))
11.1.5 ApoCell, Inc.(US) Recent Development
11.2 Biocep Ltd. (Israel)
11.2.1 Biocep Ltd. (Israel) Company Details
11.2.2 Biocep Ltd. (Israel) Business Overview
11.2.3 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.2.4 Biocep Ltd. (Israel) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
11.2.5 Biocep Ltd. (Israel) Recent Development
11.3 Biocept, Inc.(US)
11.3.1 Biocept, Inc.(US) Company Details
11.3.2 Biocept, Inc.(US) Business Overview
11.3.3 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.3.4 Biocept, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
11.3.5 Biocept, Inc.(US) Recent Development
11.4 Biofluidica MicrotechnologiesLLc(US)
11.4.1 Biofluidica MicrotechnologiesLLc(US) Company Details
11.4.2 Biofluidica MicrotechnologiesLLc(US) Business Overview
11.4.3 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.4.4 Biofluidica MicrotechnologiesLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
11.4.5 Biofluidica MicrotechnologiesLLc(US) Recent Development
11.5 Celltraffix Inc.(US)
11.5.1 Celltraffix Inc.(US) Company Details
11.5.2 Celltraffix Inc.(US) Business Overview
11.5.3 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.5.4 Celltraffix Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
11.5.5 Celltraffix Inc.(US) Recent Development
11.6 ClearbridgeBiomedics(Singapore)
11.6.1 ClearbridgeBiomedics(Singapore) Company Details
11.6.2 ClearbridgeBiomedics(Singapore) Business Overview
11.6.3 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.6.4 ClearbridgeBiomedics(Singapore) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
11.6.5 ClearbridgeBiomedics(Singapore) Recent Development
11.7 Creatv Microtech, Inc.(US)
11.7.1 Creatv Microtech, Inc.(US) Company Details
11.7.2 Creatv Microtech, Inc.(US) Business Overview
11.7.3 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.7.4 Creatv Microtech, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
11.7.5 Creatv Microtech, Inc.(US) Recent Development
11.8 CynvenioBiosystems, Inc.(US)
11.8.1 CynvenioBiosystems, Inc.(US) Company Details
11.8.2 CynvenioBiosystems, Inc.(US) Business Overview
11.8.3 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.8.4 CynvenioBiosystems, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
11.8.5 CynvenioBiosystems, Inc.(US) Recent Development
11.9 EpicBiosciencesInc.(US)
11.9.1 EpicBiosciencesInc.(US) Company Details
11.9.2 EpicBiosciencesInc.(US) Business Overview
11.9.3 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.9.4 EpicBiosciencesInc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
11.9.5 EpicBiosciencesInc.(US) Recent Development
11.10 FluxionBiosciences, Inc.(US)
11.10.1 FluxionBiosciences, Inc.(US) Company Details
11.10.2 FluxionBiosciences, Inc.(US) Business Overview
11.10.3 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
11.10.4 FluxionBiosciences, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
11.10.5 FluxionBiosciences, Inc.(US) Recent Development
11.11 Ikonisys, Inc.(US)
10.11.1 Ikonisys, Inc.(US) Company Details
10.11.2 Ikonisys, Inc.(US) Business Overview
10.11.3 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
10.11.4 Ikonisys, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
10.11.5 Ikonisys, Inc.(US) Recent Development
11.12 IVDiagnostics, Inc.(US)
10.12.1 IVDiagnostics, Inc.(US) Company Details
10.12.2 IVDiagnostics, Inc.(US) Business Overview
10.12.3 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
10.12.4 IVDiagnostics, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
10.12.5 IVDiagnostics, Inc.(US) Recent Development
11.13 JanssenDiagnosticsLLc(US)
10.13.1 JanssenDiagnosticsLLc(US) Company Details
10.13.2 JanssenDiagnosticsLLc(US) Business Overview
10.13.3 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
10.13.4 JanssenDiagnosticsLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
10.13.5 JanssenDiagnosticsLLc(US) Recent Development
11.14 QIAGEnHannoverGmbH (Germany)
10.14.1 QIAGEnHannoverGmbH (Germany) Company Details
10.14.2 QIAGEnHannoverGmbH (Germany) Business Overview
10.14.3 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Introduction
10.14.4 QIAGEnHannoverGmbH (Germany) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
10.14.5 QIAGEnHannoverGmbH (Germany) Recent Development
11.15 RARECELLsSAs(Italy)
10.15.1 RARECELLsSAs(Italy) Company Details
10.15.2 RARECELLsSAs(Italy) Business Overview
10.15.3 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Introduction
10.15.4 RARECELLsSAs(Italy) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
10.15.5 RARECELLsSAs(Italy) Recent Development
11.16 ScreenCell(France)
10.16.1 ScreenCell(France) Company Details
10.16.2 ScreenCell(France) Business Overview
10.16.3 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Introduction
10.16.4 ScreenCell(France) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
10.16.5 ScreenCell(France) Recent Development
11.17 STEMCELlTechnologies, Inc.(Canada)
10.17.1 STEMCELlTechnologies, Inc.(Canada) Company Details
10.17.2 STEMCELlTechnologies, Inc.(Canada) Business Overview
10.17.3 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Introduction
10.17.4 STEMCELlTechnologies, Inc.(Canada) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
10.17.5 STEMCELlTechnologies, Inc.(Canada) Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of CTC Enrichment
Table 3. Key Players of CTC Detection
Table 4. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 5. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 6. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 7. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Regions (2015-2020)
Table 8. Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 9. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Regions (2021-2026)
Table 10. Circulating Tumor Cell (CTC) Diagnostics Market Market Trends
Table 11. Circulating Tumor Cell (CTC) Diagnostics Market Drivers
Table 12. Circulating Tumor Cell (CTC) Diagnostics Market Challenges
Table 13. Circulating Tumor Cell (CTC) Diagnostics Market Restraints
Table 14. Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Players (2015-2020) (US$ Million)
Table 15. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Players (2015-2020)
Table 16. Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell (CTC) Diagnostics as of 2019)
Table 17. Global Circulating Tumor Cell (CTC) Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 18. Key Players Headquarters and Area Served
Table 19. Key Players Circulating Tumor Cell (CTC) Diagnostics Product Solution and Service
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 22. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Type (2015-2020)
Table 23. Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 24. Global Circulating Tumor Cell (CTC) Diagnostics Market Size Share by Application (2015-2020) (US$ Million)
Table 25. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Application (2015-2020)
Table 26. Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 27. North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 28. North America Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2015-2020)
Table 29. North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 30. North America Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2015-2020)
Table 31. North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 32. North America Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2015-2020)
Table 33. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 34. Europe Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2015-2020)
Table 35. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 36. Europe Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2015-2020)
Table 37. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 38. Europe Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2015-2020)
Table 39. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 40. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2015-2020)
Table 41. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 42. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2015-2020)
Table 43. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size by Region (US$ Million) (2015-2020)
Table 44. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share by Region (2015-2020)
Table 45. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 46. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2015-2020)
Table 47. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 48. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2015-2020)
Table 49. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 50. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2015-2020)
Table 51. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 52. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Share by Type (2015-2020)
Table 53. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 54. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Share by Application (2015-2020)
Table 55. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 56. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Share by Country (2015-2020)
Table 57. ApoCell, Inc.(US) Company Details
Table 58. ApoCell, Inc.(US) Business Overview
Table 59. ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 60. ApoCell, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 61. ApoCell, Inc.(US) Recent Development
Table 62. Biocep Ltd. (Israel) Company Details
Table 63. Biocep Ltd. (Israel) Business Overview
Table 64. Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Product
Table 65. Biocep Ltd. (Israel) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 66. Biocep Ltd. (Israel) Recent Development
Table 67. Biocept, Inc.(US) Company Details
Table 68. Biocept, Inc.(US) Business Overview
Table 69. Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 70. Biocept, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 71. Biocept, Inc.(US) Recent Development
Table 72. Biofluidica MicrotechnologiesLLc(US) Company Details
Table 73. Biofluidica MicrotechnologiesLLc(US) Business Overview
Table 74. Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 75. Biofluidica MicrotechnologiesLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 76. Biofluidica MicrotechnologiesLLc(US) Recent Development
Table 77. Celltraffix Inc.(US) Company Details
Table 78. Celltraffix Inc.(US) Business Overview
Table 79. Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 80. Celltraffix Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 81. Celltraffix Inc.(US) Recent Development
Table 82. ClearbridgeBiomedics(Singapore) Company Details
Table 83. ClearbridgeBiomedics(Singapore) Business Overview
Table 84. ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Product
Table 85. ClearbridgeBiomedics(Singapore) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 86. ClearbridgeBiomedics(Singapore) Recent Development
Table 87. Creatv Microtech, Inc.(US) Company Details
Table 88. Creatv Microtech, Inc.(US) Business Overview
Table 89. Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 90. Creatv Microtech, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 91. Creatv Microtech, Inc.(US) Recent Development
Table 92. CynvenioBiosystems, Inc.(US) Business Overview
Table 93. CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 94. CynvenioBiosystems, Inc.(US) Company Details
Table 95. CynvenioBiosystems, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 96. CynvenioBiosystems, Inc.(US) Recent Development
Table 97. EpicBiosciencesInc.(US) Company Details
Table 98. EpicBiosciencesInc.(US) Business Overview
Table 99. EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 100. EpicBiosciencesInc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 101. EpicBiosciencesInc.(US) Recent Development
Table 102. FluxionBiosciences, Inc.(US) Company Details
Table 103. FluxionBiosciences, Inc.(US) Business Overview
Table 104. FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 105. FluxionBiosciences, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 106. FluxionBiosciences, Inc.(US) Recent Development
Table 107. Ikonisys, Inc.(US) Company Details
Table 108. Ikonisys, Inc.(US) Business Overview
Table 109. Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 110. Ikonisys, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 111. Ikonisys, Inc.(US) Recent Development
Table 112. IVDiagnostics, Inc.(US) Company Details
Table 113. IVDiagnostics, Inc.(US) Business Overview
Table 114. IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 115. IVDiagnostics, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 116. IVDiagnostics, Inc.(US) Recent Development
Table 117. JanssenDiagnosticsLLc(US) Company Details
Table 118. JanssenDiagnosticsLLc(US) Business Overview
Table 119. JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product
Table 120. JanssenDiagnosticsLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 121. JanssenDiagnosticsLLc(US) Recent Development
Table 122. QIAGEnHannoverGmbH (Germany) Company Details
Table 123. QIAGEnHannoverGmbH (Germany) Business Overview
Table 124. QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Product
Table 125. QIAGEnHannoverGmbH (Germany) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 126. QIAGEnHannoverGmbH (Germany) Recent Development
Table 127. RARECELLsSAs(Italy) Company Details
Table 128. RARECELLsSAs(Italy) Business Overview
Table 129. RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Product
Table 130. RARECELLsSAs(Italy) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 131. RARECELLsSAs(Italy) Recent Development
Table 132. ScreenCell(France) Company Details
Table 133. ScreenCell(France) Business Overview
Table 134. ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Product
Table 135. ScreenCell(France) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 136. ScreenCell(France) Recent Development
Table 137. STEMCELlTechnologies, Inc.(Canada) Company Details
Table 138. STEMCELlTechnologies, Inc.(Canada) Business Overview
Table 139. STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Product
Table 140. STEMCELlTechnologies, Inc.(Canada) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020) (US$ Million)
Table 141. STEMCELlTechnologies, Inc.(Canada) Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. CTC Enrichment Features
Figure 3. CTC Detection Features
Figure 4. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Application: 2020 VS 2026
Figure 5. Hospitals and clinics Case Studies
Figure 6. Pharmaceuticals and biotechnology companies Case Studies
Figure 7. Academic research institutes Case Studies
Figure 8. CROs Case Studies
Figure 9. Circulating Tumor Cell (CTC) Diagnostics Report Years Considered
Figure 10. Global Circulating Tumor Cell (CTC) Diagnostics Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Regions: 2020 VS 2026
Figure 12. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Regions (2021-2026)
Figure 13. Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Players in 2019
Figure 14. Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cell (CTC) Diagnostics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2019
Figure 16. North America Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Circulating Tumor Cell (CTC) Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. ApoCell, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 42. Biocep Ltd. (Israel) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 43. Biocept, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 44. Biofluidica MicrotechnologiesLLc(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 45. Celltraffix Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 46. ClearbridgeBiomedics(Singapore) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 47. Creatv Microtech, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 48. CynvenioBiosystems, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 49. EpicBiosciencesInc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 50. FluxionBiosciences, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 51. Ikonisys, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 52. IVDiagnostics, Inc.(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 53. JanssenDiagnosticsLLc(US) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 54. QIAGEnHannoverGmbH (Germany) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 55. RARECELLsSAs(Italy) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 56. ScreenCell(France) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 57. STEMCELlTechnologies, Inc.(Canada) Revenue Growth Rate in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group 710497

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Global Circulating Tumor Cell (CTC) Diagnostics Market Size, Status and Forecast 2021-2027 Circulating Tumor Cell (CTC) Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cell (CTC) Diagnostics market will be able to gain t...
Global Circulating Tumor Cell (CTC) Detector Market Growth 2021-2026 According to this latest study, the 2020 growth of Circulating Tumor Cell (CTC) Detector will have significant change from previous year. By the most conservative estimates of global Circulating Tumor Cell (CTC) Detector market size (most likely outc...
2020-2025 Global and Regional Circulating Tumor Cell (CTC) Diagnostics Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report HNY Research projects that the Circulating Tumor Cell (CTC) Diagnostics market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2...
Global Circulating Tumor Cell (CTC) Diagnostics Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026 According to HJ Research's study, the global Circulating Tumor Cell (CTC) Diagnostics market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. ...
Circulating Tumor Cell (CTC) Diagnostics Market Insights 2019, Global and Chinese Analysis and Forecast to 2024 Circulating Tumor Cell (CTC) Diagnostics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Circulating Tumor Cell (CTC) Diagnostics industry with a focus on the Chinese market. T...
COVID-19 Impact on Circulating Tumor Cell (CTC) Diagnostics Market, Global Research Reports 2020-2021 This report covers market size and forecasts of Circulating Tumor Cell (CTC) Diagnostics, including the following market information: Global Circulating Tumor Cell (CTC) Diagnostics Market Size, 2019-2021, and 2020 ...
Impact of COVID-19 Outbreak on Circulating Tumor Cell (CTC) Detector, Global Market Research Report 2020 The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segme...
Global Circulating Tumor Cell (CTC) Detector Market Growth 2020-2025 According to this study, over the next five years the Circulating Tumor Cell (CTC) Detector market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this r...
Global Circulating Tumor Cell (CTC) Diagnostics Market Growth (Status and Outlook) 2020-2025 According to this study, over the next five years the Circulating Tumor Cell (CTC) Diagnostics market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, thi...
Global Circulating Tumor Cell (CTC) Diagnostics Market Insights, Forecast to 2025 Circulating tumor cells (CTCs) are cells that have shed into the vasculature or lymphatics from a primary tumor and are carried around the body in the blood circulation. Global Circulating Tumor Cell (CTC) Diagnostics market size will increase...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *